POSITRON Q1 Revenue Dips 7% to $111K, Narrows Net Loss to $1.38M
summarizeSummary
POSITRON CORP reported first-quarter 2026 results, showing revenue of $111K, a 7% decline year-over-year, and a net loss of $(1.38M), which narrowed from the prior-year quarter. Diluted loss per share improved to $(0.04). This update follows the company's last 10-K, which included a going concern warning and highlighted significant financial and operational challenges. While the narrowing of the net loss and improved EPS offer a mixed signal, the company continues to operate at a substantial loss, and revenue declined. Investors will need to monitor if the recently expanded OEM/distribution partnership and product roadmap momentum can translate into sustainable revenue growth and a clearer path to profitability, especially given the persistent financial concerns.
At the time of this announcement, POSC was trading at $1.95 on OTC in the Life Sciences sector, with a market capitalization of approximately $63.9M. The 52-week trading range was $1.23 to $2.74. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.